PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsFor46
For46
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
113 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Colorectal neoplasmsD015179219434
Pancreatic neoplasmsD010190EFO_0003860C2521321219
CarcinomaD002277C80.041139
Liver neoplasmsD008113EFO_1001513C22.02147
Neoplasm metastasisD009362EFO_0009708112
Neuroendocrine carcinomaD018278112
Chronic obstructive pulmonary diseaseD029424EFO_0000341J44.911
EmphysemaD004646EFO_0000464J4311
AmyloidosisD000686EFO_1001875E8511
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Rectal neoplasmsD0120045117
MelanomaD0085452316
Macular edemaD008269122
EdemaD004487R60.9122
Chemotherapy-induced febrile neutropeniaD06414611
SchizophreniaD012559EFO_0000692F2011
Head and neck neoplasmsD00625811
StomatitisD013280EFO_1001904K12.111
PhenylketonuriasD010661E70.011
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hepatocellular carcinomaD006528C22.0448
AdenocarcinomaD0002301517
Pancreatic ductal carcinomaD021441224
Prostatic neoplasmsD011471C61223
Stomach neoplasmsD013274EFO_0003897C1622
Esophageal neoplasmsD004938C1522
ObesityD009765EFO_0001073E66.9112
LymphomaD008223C85.9112
Castration-resistant prostatic neoplasmsD064129122
Gastrointestinal neoplasmsD005770C26.9112
Show 20 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Non-hodgkin lymphomaD008228C85.911
Follicular lymphomaD008224C8211
Multiple myelomaD009101C90.011
Plasma cell neoplasmsD05421911
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369C8033
Vascular system injuriesD057772T14.811
Overactive urinary bladderD053201EFO_1000781N32.8111
Nutrition disordersD009748EFO_000106911
Psychosocial functioningD00008362311
ExerciseD015444EFO_000048311
AnorexiaD000855R63.011
Anorexia nervosaD000856EFO_0004215F50.011
Nasopharyngeal carcinomaD00007727411
RadiotherapyD01187811
Show 18 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name
INN
Description
Classification
Unknown
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL ID
ChEBI ID
PubChem CID
DrugBank
UNII ID
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use